Pfizer

Summary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe…

Summary : EMA’s human medicines committe  has recommended granting  conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 / ritonavir) for…

Synopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical study to evaluate the safety,…

Synopsis: Pfizer’s JAK inhibitor Xeljanz and Novartis’ S1P modulator Gilenya both have their share of safety problems. But Vyne Therapeutics thinks it…

Synopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies…

Synopsis- The provisional approval is for two doses of the paediatric Pfizer COVID-19 vaccine, given at least 21 days apart, the health…

Summary: The clinical trial results show that the vaccine is safe and effective in this in this age group, it will thus…

Summary – Pfizer says the protection provided by two doses of its anti-COVID-19 vaccine against previous strains will match that provided by…

Summary : The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that…

Synopsis:  The Therapeutic Goods Administration has provisionally approved the Comirnaty (Pfizer) vaccine as safe and effective for use among 5 to 11-year-old…